A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells

TSLP Conditions the Lung Immune Environment for the Generation of Pathogenic Innate and Antigen-Specific Adaptive Immune Responses

(2014) M. B. Headley et al.   JOURNAL OF IMMUNOLOGY

Thymic stromal lymphopoietin

(2010) Rui He et al.   Annals of the New York Academy of Sciences

Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling

(2010) Y. Rochman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Th9 and allergic disease

(2009) Pejman Soroosh et al.   IMMUNOLOGY

BCG Priming of Dendritic Cells Enhances T Regulatory and Th1 Function and Suppresses Allergen-Induced Th2 Function in vitro and in vivo

(2009) B. Ahrens et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Diesel Exhaust Particles Stimulate Adaptive Immunity by Acting on Pulmonary Dendritic Cells

(2009) Sharen Provoost et al.   JOURNAL OF IMMUNOLOGY

Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma

(2009) Z. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA